Ferritin: Sex- and Cycle-Related Differences, Normal Ranges, and Optimal Targets

What Ferritin Measures and Why It Matters

Ferritin is a hollow, spherical protein that stores up to 4,500 iron atoms per molecule and releases them when systemic demand rises. Serum ferritin is a proxy for total iron stores: 1 ng/mL corresponds roughly to 8 mg of stored iron in healthy adults [1]. Low ferritin precedes anemia by weeks to months, making it the earliest detectable signal of iron depletion.

Iron depletion affects far more than red blood cells. Depleted stores reduce activity of iron-dependent enzymes in the thyroid peroxidase pathway, the mitochondrial electron transport chain, and the dopaminergic neurons of the substantia nigra. This explains the well-documented links between low ferritin and hair loss, fatigue, cognitive slowing, and restless legs syndrome, all of which can appear before hemoglobin falls even one gram [2].

Ferritin Is Also an Acute-Phase Reactant

Because hepatocytes upregulate ferritin synthesis during inflammation, a "normal" ferritin result can mask true iron depletion in someone with active infection, autoimmune disease, or metabolic dysfunction. The 2023 American Society of Hematology guidelines recommend interpreting ferritin alongside C-reactive protein (CRP): if CRP exceeds 5 mg/L, ferritin may be falsely elevated by 30 to 50% relative to true stores [3].

A ferritin of 40 ng/mL alongside a CRP of 15 mg/L may reflect genuinely empty iron stores. Interpreting the two values together is standard practice in clinical iron assessment.

Why Reference Ranges Are Set So Low

Current lower limits of normal for ferritin (12 ng/mL in most female ranges) were derived from population distributions, not from the ferritin level at which symptoms resolve or tissue enzymes function optimally. A 2003 analysis in the British Journal of Haematology showed that hair-cycle arrest resolves when ferritin exceeds 40 ng/mL, a threshold that sits above the "normal" lower boundary used by most commercial labs at the time [4].

Sex Differences in Ferritin: Why Women Consistently Run Lower

Premenopausal women carry ferritin levels roughly 60 to 75% lower than age-matched men. This is not incidental. Three biological mechanisms drive the gap.

Menstrual Blood Loss

Each menstrual cycle costs approximately 12 to 15 mg of iron, though losses vary between 5 mg and more than 80 mg depending on flow volume [5]. Women with heavy menstrual bleeding (HMB, defined as more than 80 mL per cycle by the 2011 FIGO classification) lose two to three times that amount. A 2021 study in Blood Advances (N=1,275) found that 41% of reproductive-age women with HMB had ferritin below 15 ng/mL despite normal hemoglobin [6].

Dietary iron absorption averages 1 to 2 mg/day for most women, making it biologically impossible to fully offset heavy losses through food alone without a sustained dietary surplus of heme iron.

Estrogen and Iron Metabolism

Estrogen increases hepcidin suppression, which raises intestinal iron absorption slightly, but this effect is modest and does not close the gap created by menstrual loss. More relevant is the finding that 17-beta-estradiol upregulates transferrin receptor expression on enterocytes, mildly increasing mucosal iron uptake [7]. Despite this, the net iron balance across the reproductive years remains negative for a significant portion of women.

Progesterone has no direct demonstrated effect on iron absorption, but luteal-phase progesterone rise is coincidentally timed with the post-menstrual ferritin recovery window, creating a cycle-phase pattern discussed in the next section.

Testosterone's Role in Men

Testosterone stimulates erythropoiesis through EPO upregulation, which increases red cell mass and consequently iron utilization. Men undergoing testosterone replacement therapy (TRT) with injectable testosterone cypionate 100 to 200 mg/week frequently show rising hemoglobin and falling ferritin over the first 3 to 6 months as iron is redistributed into expanding red cell mass [8]. Clinicians prescribing TRT should check ferritin at baseline and again at 3 months. A ferritin drop below 40 ng/mL warrants oral iron supplementation, even in the absence of frank anemia.

How the Menstrual Cycle Shifts Ferritin Week by Week

Ferritin is not a static number across the cycle. A 2019 longitudinal study in European Journal of Clinical Nutrition (N=59 premenopausal women, daily blood draws across one complete cycle) documented a mean 22% ferritin reduction from the late luteal phase to day 3 of menstruation, with nadir values occurring on cycle days 2 to 4 [9]. Recovery to near-peak values took approximately 10 to 14 days.

Practical Implications for Lab Timing

Testing ferritin during the menstrual phase can produce values 20 to 30% lower than the woman's true mid-cycle baseline. A woman with a mid-cycle ferritin of 55 ng/mL might test at 38 to 42 ng/mL on day 2 of her period. Both values fall within some labs' "normal" range, yet the clinical meaning differs substantially.

The standard clinical instruction for optimizing ferritin measurement accuracy in cycling women: draw the sample between cycle day 7 and day 21, and note the cycle day on the lab requisition. This recommendation aligns with guidance from the British Society for Haematology on iron status assessment in women of reproductive age [10].

Heavy Menstrual Bleeding and Cycle-Driven Depletion

In women with HMB, the cycle-nadir effect is amplified. Ferritin may reach single-digit values on days 1 to 3 in women who were already marginally replete. Iron infusion therapy, rather than oral supplementation, becomes relevant when ferritin falls below 15 ng/mL with concurrent symptoms: the IV iron formulation ferric carboxymaltose (Injectafer) is FDA-approved for iron deficiency in adults who cannot tolerate or absorb oral iron, and a single 1,000 mg IV dose can restore ferritin from below 15 ng/mL to above 100 ng/mL within three weeks [11].

Optimal Ferritin Targets: Where the Evidence Points

The gap between "not anemic" and "optimal" is wide for ferritin.

Hair Loss and Ferritin

Hair follicle cycling requires iron-dependent ribonucleotide reductase activity. A 2006 review in the Journal of the American Academy of Dermatology concluded that ferritin below 40 ng/mL is associated with telogen effluvium in women, though the authors noted that controlled trials at the time were limited [12]. More recent clinical practice at specialized hair-loss centers uses a target of 70 to 100 ng/mL before concluding that iron depletion is not contributing to shedding.

The 2023 American Academy of Dermatology (AAD) guidelines on female pattern hair loss list iron deficiency as a modifiable contributing factor and recommend correcting ferritin to above 40 ng/mL as part of initial management, though individual practitioners often target higher [13].

Restless Legs Syndrome and Ferritin

The dopamine synthesis pathway in the substantia nigra is iron-dependent. The 2022 International Restless Legs Syndrome Study Group (IRLSSG) guidelines recommend checking ferritin in all patients with RLS and treating if ferritin is below 75 ng/mL, using oral iron as first-line for ferritin in the 50 to 75 ng/mL range and IV iron for ferritin below 50 ng/mL with moderate-to-severe symptoms [14]. This guideline-derived threshold of 75 ng/mL sits 50 to 60 points above what most lab reports would flag as low.

Thyroid Function and Ferritin

Thyroid peroxidase requires iron as a cofactor for the synthesis of T4 and T3. Observational data from a 2013 study in Thyroid (N=2,718) showed that women with ferritin below 30 ng/mL had a 3.1-fold higher odds of subclinical hypothyroidism compared to women with ferritin above 60 ng/mL, after adjusting for age and TSH reference range [15]. Women presenting with fatigue, cold intolerance, or hair thinning who have borderline TSH values deserve ferritin testing as part of the same workup.

Longevity Medicine Targets

Functional and longevity clinicians generally use a tiered target framework based on sex and reproductive status:

| Population | Minimum Functional Target | Optimal Target | |---|---|---| | Premenopausal women | 50 ng/mL | 70 to 100 ng/mL | | Postmenopausal women | 70 ng/mL | 100 to 150 ng/mL | | Men (all ages) | 70 ng/mL | 100 to 150 ng/mL | | Men on TRT (first 6 months) | 60 ng/mL | Monitor monthly | | Patients with RLS | 75 ng/mL (per IRLSSG 2022) | 100+ ng/mL |

Values above 200 ng/mL in the absence of acute illness warrant investigation for hereditary hemochromatosis, liver disease, or chronic inflammation before any iron supplementation continues.

Postmenopausal Shift: Why Ferritin Rises After Menopause

Ferritin climbs substantially after menopause, and postmenopausal women's values begin to approach male ranges within 5 to 10 years of final menstrual period. A large cross-sectional analysis of NHANES data (N=15,239) published in Blood in 2017 showed that median ferritin in women aged 50 to 59 was 84 ng/mL, compared to 32 ng/mL in women aged 20 to 39, a 163% increase explained primarily by the cessation of menstrual blood loss [16].

This rise has two clinical implications. First, postmenopausal women presenting with fatigue or hair loss who have ferritin of 35 ng/mL are iron-deficient relative to their age group's expected values and deserve investigation for occult gastrointestinal blood loss. Second, postmenopausal women with ferritin above 250 ng/mL without inflammatory markers should be evaluated for hemochromatosis gene variants (HFE C282Y and H63D), which become clinically expressed more readily after the protective effect of menstrual iron loss disappears.

HRT, Oral Contraceptives, and Ferritin

Combined Oral Contraceptives

Combined oral contraceptive pills (COCPs) reduce menstrual blood loss by 40 to 50% on average, which predictably raises ferritin over 6 to 12 months of use. A 2020 study in Contraception (N=488) showed mean ferritin increased from 29 ng/mL to 47 ng/mL after 12 months of COCP use in previously iron-replete women, a finding relevant to women who discontinue the pill and then develop symptomatic iron depletion over the following 6 to 12 months as heavier cycling resumes [17].

Hormone Replacement Therapy in Menopause

Estrogen-containing HRT in postmenopausal women modestly suppresses the post-menopausal ferritin rise. The Women's Health Initiative observational cohort found that HRT users had ferritin values approximately 12 to 18 ng/mL lower than non-users at equivalent ages, likely reflecting both mild hemodilution from estrogen-driven plasma volume expansion and mild upregulation of iron utilization [18]. The clinical effect is modest and does not typically require supplementation adjustments for most women.

Testosterone Therapy in Women

Low-dose testosterone therapy in women (typical doses: 0.5 to 2 mg/day transdermal) has not been shown to produce the same degree of erythrocytosis seen in men at TRT doses. However, women with androgen deficiency treated with testosterone pellets at higher doses may show a modest hemoglobin increase over 3 to 6 months, warranting a follow-up ferritin check at the 3-month mark [19].

Diagnosing Iron Deficiency: Ferritin in Context

Serum ferritin does not tell the whole story alone. A complete iron panel includes:

• Serum ferritin (stores)
• Serum iron (circulating)
• Total iron-binding capacity (TIBC)
• Transferrin saturation (serum iron divided by TIBC, expressed as a percentage)

Iron deficiency without anemia: ferritin below 30 ng/mL, transferrin saturation below 20%, normal hemoglobin. This pattern requires treatment even without anemia, per the 2021 European Society of Cardiology guidelines on iron deficiency in heart failure, which use a ferritin threshold of 100 ng/mL (or 100 to 299 ng/mL with transferrin saturation below 20%) as the treatment trigger [20].

Iron deficiency anemia: ferritin below 15 ng/mL with hemoglobin below 12 g/dL in women or below 13 g/dL in men (WHO thresholds) [21]. At this stage, oral iron supplementation alone may take 3 to 6 months to restore stores, and IV iron should be considered for symptomatic patients or those with malabsorption.

Oral Iron: Dosing and Schedule

The most studied form of oral iron is ferrous sulfate 325 mg (65 mg elemental iron). A 2017 study in The Lancet Haematology (N=90) showed that alternate-day dosing (every other day) produced superior fractional iron absorption compared to daily dosing because daily iron acutely raises hepcidin for 24 hours, temporarily blocking further intestinal absorption [22]. The preferred schedule for most adult women: 65 mg elemental iron on alternate mornings, taken with 250 mg of vitamin C to improve absorption.

Ferritin, Inflammation, and Interpreting High Values

Ferritin above 300 ng/mL in men or above 200 ng/mL in women always requires interpretation alongside inflammatory markers. The differential includes:

• Hereditary hemochromatosis (HFE gene mutations): ferritin often 500 to 3,000 ng/mL with elevated transferrin saturation above 45%
• Non-alcoholic fatty liver disease (NAFLD): ferritin 200 to 500 ng/mL, often with elevated ALT and normal transferrin saturation
• Chronic inflammatory conditions (rheumatoid arthritis, inflammatory bowel disease): elevated ferritin with elevated CRP
• Adult-onset Still's disease: ferritin may exceed 10,000 ng/mL
• Hemophagocytic lymphohistiocytosis: ferritin commonly above 10,000 ng/mL [23]

The 2022 European Association for the Study of the Liver (EASL) guidelines on hemochromatosis specify that genetic testing for HFE C282Y and H63D should follow any unexplained ferritin above 200 ng/mL in women or above 300 ng/mL in men with transferrin saturation at or above 45% [24].

Clinical Testing Recommendations by Population

Testing frequency and interpretation vary meaningfully by patient profile. The following framework reflects current society guidance and functional-medicine practice:

Premenopausal women with fatigue, hair loss, or RLS: Test ferritin at cycle days 7 to 21. Add CRP, serum iron, and TIBC in the same draw. Repeat 3 months after any supplementation intervention.

Women starting or stopping hormonal contraception: Baseline ferritin before stopping COCP, with a 6-month recheck to detect depletion from resumed cycling.

Men starting TRT: Baseline ferritin, CBC, and iron panel before initiation. Recheck at 3 months. Treat if ferritin drops below 50 ng/mL.

Postmenopausal women with ferritin above 200 ng/mL: Add CRP and transferrin saturation. If transferrin saturation exceeds 45%, proceed to HFE genotyping per EASL 2022 guidance [24].

Adults with confirmed RLS: Target ferritin above 75 ng/mL per IRLSSG 2022 guidelines, using IV iron if ferritin is below 50 ng/mL and symptoms are moderate to severe [14].

For most adults without inflammatory conditions, serum ferritin below 50 ng/mL warrants a clinical conversation about iron sufficiency regardless of what the lab reference range prints as "normal."